Otsuka (OTSKY) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. is a Japan-based holding company whose businesses focus primarily on pharmaceuticals and nutraceuticals. Its group companies research, develop, manufacture, and market prescription medicines, consumer health products, and medical devices.

Otsuka’s pharmaceutical portfolio includes treatments across areas such as mental health, kidney disease, and oncology. Its nutraceutical business offers products including Pocari Sweat and CalorieMate, alongside other nutrition and wellness products.

The company’s roots trace to Otsuka Pharmaceutical Factory, founded in Japan in 1921. Otsuka Holdings was established as a holding company in 2008, and its operating businesses serve customers in Japan and international markets.

Key Stats

• Today's Range: $38.37 to $38.57
• 50-Day Range: $34.88 to $39.65
• 52-Week Range: $26.11 to $40.92
• Volume: 12,025 shs
• Average Volume: 41,067 shs
• Market Capitalization: $41.43 billion
• P/E Ratio: 16.55
• Dividend Yield: 0.96%
• Price Target: N/A
• Consensus Rating: Hold

Otsuka Stock Analysis - MarketRank™

Otsuka scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Otsuka has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Otsuka has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.33%

Earnings Growth

Earnings for Otsuka are expected to grow by 6.33% in the coming year, from $2.21 to $2.35 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Otsuka is 16.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.40.

Price to Earnings Ratio vs. Sector

The P/E ratio of Otsuka is 16.55, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.60.

Price to Earnings Growth Ratio

Otsuka has a PEG Ratio of 2.74. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Otsuka has a P/B Ratio of 2.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Otsuka has been sold short.

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 0.08, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Otsuka has recently decreased by 92.63%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Otsuka has a dividend yield of 0.98%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Otsuka does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Otsuka is 15.88%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Otsuka will have a dividend payout ratio of 15.74% next year. This indicates that Otsuka will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: -0.50

News Sentiment

Otsuka has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Otsuka this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Otsuka insiders have not sold or bought any company stock.

Percentage Held by Institutions

Otsuka has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 10/30/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:OTSKY
• Previous Symbol: OTCMKTS:OTSKY
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 37,758
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $2.33
• Trailing P/E Ratio: 16.55
• Forward P/E Ratio: 16.41
• P/E Growth: 2.74
• Net Income: $2.43 billion
• Net Margins: 14.36%
• Pretax Margin: N/A
• Return on Equity: 11.90%
• Return on Assets: 8.91%

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 2.21
• Quick Ratio: 1.65

Sales & Book Value

• Annual Sales: $16.51 billion
• Price / Sales: 2.51
• Cash Flow: $3.04 per share
• Price / Cash Flow: 12.69
• Book Value: $19.33 per share
• Price / Book: 2.00

Miscellaneous

• Outstanding Shares: 1,074,190,000
• Free Float: N/A
• Market Cap: $41.43 billion
• Optionable: Not Optionable
• Beta: 0.08